Original news and analysis on international IP policy
The Global Fund to Fight AIDS, Tuberculosis and Malaria has launched an initiative with other agencies aimed at expanding global access to health products such as medicines. But the Fund has had some explaining to do about the initiative, which some say could encompass a plan to allow different prices based on national income levels.
The Medicines Patent Pool (MPP) this week announced two new licencing agreements with the private sector joint venture ViiV Healthcare that will increase access to a new antiretroviral in countries hardest hit by HIV.
UNITAID has published the full version of its report on “The Trans-Pacific Partnership Agreement: Implications for Access to Medicines and Public Health.”
Representatives of private sector, international organisations and others from Europe and Africa this week delivered a set of recommendations on health and pharmaceuticals to the two regions’ leaders ahead of their summit taking place today and tomorrow.
As bacteria become more and more resistant to existing medicines, product pipelines are drying up. A solution may lie in a forgotten therapy developed in 1917, the use of which has been restricted to certain parts of Eastern Europe ever since the discovery and universal use of antibiotics. But business models and intellectual property regimes need to change to provide incentives for research and development in this area.
The World Health Organization this week is holding an information consultation with member states on the UN agency's engagement with “non-state actors.” The meeting follows a request by member states at the January WHO Executive Board to pursue discussions on a framework for the organisation's engagement with non-state actors, which has been changing in recent years.
Australia yesterday took the unusual move of agreeing to the first request by Indonesia to establish a World Trade Organization dispute panel against it. The ready acceptance of the panel request was an attempt by Australia to bring the some or all of the five separate cases against its tobacco plain packaging law together for resource reasons and to protect the integrity of the WTO dispute settlement mechanism, it said in a statement to the Dispute Settlement Body.
In time for World TB Day today, an analysis has been published of research and development being carried out for tuberculosis by the 20 largest pharmaceutical companies.
The issue of medicines access for low-income people in developing countries has been of major concern to global health policymakers for years. A key issue is the inability of northern pharmaceutical producers to develop and distribute affordable medicines and recover their research and development costs.
As part of the effort to address this, a non-governmental group was formed in coordination with industry and other stakeholders to develop an index to rate companies’ efforts to ameliorate the situation.
Julia Fraser for Intellectual Property Watch recently sat down with Hans Hogerzeil, a former senior World Health Organization official and a top strategist for the Access to Medicine Index, to discuss the index’s impact, independence and the future.
The European Parliament is scheduled to vote on 3 April on amended draft legislation that would oblige pharmaceutical companies to publish all clinical trial data in a publicly accessible database.
KAMPALA - In the western terrains of Uganda, in a refugee camp, Dr. Moses Kizza Musaazi invented and is running a simple but ingenious scheme. Making environmentally friendly sanitary pads out of papyrus reeds. The pads, MakaPads sanitary pads, are the only trademarked biodegradable sanitary pads made in Africa. Dr. Musaazi developed the idea and technique while looking for a way to help school-going girls.
A recent book by a UK journalist and lecturer illustrates that recent reforms in global public health policy have ignored public health needs in favour of market-based ideologies.